Early High Efficacy Treatment in Multiple Sclerosis Is the Best Predictor of Future Disease Activity Over 1 and 2 Years in a Norwegian Population-Based Registry

Background: Moderate and high efficacy disease modifying therapies (DMTs) have a profound effect on disease activity. The current treatment guidelines only recommend high efficacy DMTs for patients with highly active MS. The objective was to examine the impact of initial treatment choice in achievin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Neurol
Main Authors: Simonsen, Cecilia Smith, Flemmen, Heidi Øyen, Broch, Line, Brunborg, Cathrine, Berg-Hansen, Pål, Moen, Stine Marit, Celius, Elisabeth Gulowsen
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Neurology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8248666/
https://ncbi.nlm.nih.gov/pubmed/34220694
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2021.693017
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados